CLINICAL TRIAL SUMMARY

MDACC Study No:SWOG0809 (clinicaltrials.gov NCT No: NCT00789958)
Title:A PhaseII Trial Of Adjuvant Capecitabine/Gemcitabine Chemotherapy Followed By Concurrent Capecitabine and Radiotherapy In Extrahepatic Cholangiocarcinoma (EHCC)
Principal Investigator:Christopher H. Crane
Treatment Agent:Capecitabine; Gemcitabine; Radiotherapy
Study Status:Terminated
Study Description:Unavailable

Hide details for General InformationGeneral Information

Disease Group:Gastrointestinal
Phase of Study:Phase I/Phase II
Treatment Agents:Capecitabine
Gemcitabine
Radiotherapy
Treatment Location:Both at MDACC & and Other Sites
Estimated Length of Stay in Houston:
Supported By:Southwest Oncology Group
Return Visit:
Home Care:


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Christopher H. Crane
Dept:Radiation Oncology
For Clinical Trial Enrollment:713-563-2300
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults